Derek Chase is the first person to receive Stereotactic ablative radiotherapy at the Royal United Hospital, a method that reduces the required treatment sessions from 20 to five. By delivering radiation with higher accuracy, the procedure minimises damage to healthy tissue and offers a more convenient option for the 17,500 men diagnosed with low and intermediate-risk prostate cancer in England each year.